4.54

2.48% 0.11

Psyence Biomedical Ltd (PBM)

Overview News Price History Discussions Forecast

Psyence Biomedical Ltd stock is traded at $4.54, with a volume of 26,989. It is up +2.48% in the last 24 hours and up +42.32% over the past month. Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Previous Close:

$4.43

Open:

$4.38

24h Volume:

26,989

Relative Volume:

0.33

Market Cap:

$17.32M

Revenue:

Net Income/Loss:

$1.52M

P/E Ratio:

-0.7182

EPS:

-6.3213

Net Cash Flow:

$-1.14M

1W Performance:

+7.84%

1M Performance:

+42.32%

6M Performance:

+75.29%

1Y Performance:

-71.84%

1-Day Range:

$4.325

$4.71

1-Week Range:

$4.10

$4.71

52-Week Range:

$0.6254

$34.62

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name

Psyence Biomedical Ltd

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-09-28

Latest SEC Filings

PBM's Discussions on Twitter

Compare PBM vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBM Psyence Biomedical Ltd	4.54	14.99M	0	1.52M	-1.14M	-6.3213
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Psyence Biomedical Ltd Stock (PBM) Latest News

Aug 19, 2026

Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - Kalkine

Aug 19, 2026

Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development - marketscreener.com

Aug 19, 2026

Aug 18, 2026

Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Nigeria

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Australia

Aug 18, 2026

Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingSeasonality Effect - vinanet.vn

Aug 18, 2026

Psyence BioMed Welcomes White House Support for Accelerated U.S. Ibogaine Development - Quiver Quantitative

Aug 18, 2026

Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development - Yahoo Finance Singapore

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement - Investing.com

Aug 18, 2026

Ibogaine could rise as potential psychedlic treatment with Trump announcement - Seeking Alpha

Aug 18, 2026

Aug 15, 2026

Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsLong Setup Ideas - vinanet.vn

Aug 15, 2026

Aug 11, 2026

Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et

Aug 11, 2026